Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond?

OBJECTIVES: Once-monthly intramuscular extended-release naltrexone (XR-NTX) has demonstrated efficacy for the prevention of relapse in opioid dependence, providing an alternative to agonist or partial agonist maintenance (ie, methadone and buprenorphine). The question remains, for whom is this uniqu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunes, Edward V., Krupitsky, Evgeny, Ling, Walter, Zummo, Jacqueline, Memisoglu, Asli, Silverman, Bernard L., Gastfriend, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450918/
https://www.ncbi.nlm.nih.gov/pubmed/25901451
http://dx.doi.org/10.1097/ADM.0000000000000125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450918/
https://www.ncbi.nlm.nih.gov/pubmed/25901451
http://dx.doi.org/10.1097/ADM.0000000000000125

Ejemplares similares